Novo Nordisk rebounds as Kepler upgrades Ozempic maker at long last
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Benzinga.com16d
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
Plaintiffs argue the decision violates the Administrative Procedure Act by bypassing required notice-and-comment rulemaking. The plaintiffs argue that this action was arbitrary, unlawful, and ...
NJBIZ17d
Drug compounders sue FDA over Novo Nordisk’s Ozempic, Wegovy (updated)
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug Wegovy and diabetes treatment Ozempic without a fight. An industry group ...
MarketWatch17d
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...
Wall Street Journal18d
Novo Nordisk Stock Rises on Weight-Loss Retreat by Hims & Hers
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood ...
Pharmabiz18d
US FDA declares Wegovy & Ozempic shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses
Novo Nordisk announced that the US Food and Drug Administration (FDA) has determined the shortage of Wegovy and Ozempic is resolved. The FDA's assessment confirms the US supply of these ...
24/7 Wall St18d
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?
The shortage of Ozempic allowed competitors to steal market share from Novo Nordisk Even with the shortage, Novo Nordisk saw fourth-quarter Wegovy sales more than double to 19.9 billion Danish ...
Philadelphia Tribune19d
Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage ... semaglutide injections from drug manufacturer Novo Nordisk follows just two months after the FDA ...
CBS News20d
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...
Wall Street Journal21d
FDA Declares Shortage of Novo Nordisk’s Wegovy, Ozempic Over
The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B-3.02%decrease; red down pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...
The Hill21d
Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms ... to sell copycat versions of the drugs while they were in shortage. Novo Nordisk, the manufacturer of semaglutide, confirmed in a statement Friday ...